Design and analysis issues in gene and environment studies

Environmental Health: A Global Access Science Source

Volumn 11, Issue 1, 2012, Pages

  Liu, Chen Yu ^a,b   Maity, Arnab ^a,c   Lin, Xihong ^a   Wright, Robert O ^a,d   Christiani, David C ^a,e  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Critical developmental windows; Epigenetics; Expanded environmental genomic disease paradigm; Gene environment; Genome wide; Interactions

Indexed keywords

BIOTECHNOLOGY; ENVIRONMENTAL CONDITIONS; EPIDEMIOLOGY; ETIOLOGY; GENETIC MARKER; GENETIC STRUCTURE; GENOMICS; GENOTYPE-ENVIRONMENT INTERACTION; PHENOTYPE; PUBLIC HEALTH; STATISTICAL ANALYSIS;

COHORT ANALYSIS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EPIGENETICS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENOMICS; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HEREDITY; HUMAN; LONGITUDINAL STUDY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SAMPLE SIZE;

CONFOUNDING FACTORS (EPIDEMIOLOGY); ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGIC RESEARCH DESIGN; EPIDEMIOLOGIC STUDIES; EPIGENESIS, GENETIC; GENE-ENVIRONMENT INTERACTION; HUMANS; SELECTION BIAS;

EID: 84872769763     PISSN: None     EISSN: 1476069X     Source Type: Journal    
DOI: 10.1186/1476-069X-11-93     Document Type: Review

References (122)

1. Case-control studies of common alleles and environmental factors. Caporaso N, Rothman N, Wacholder S, J Natl Cancer Inst Monogr 1999 26 25 30 10854482
2. Cohort studies for characterizing measured genes. Langholz B, et al. J Natl Cancer Inst Monogr 1999 26 39 42 10854484
3. Inference issues in cohort and case-control studies of genetic effects and gene-environment interactions. Garcia-Closas M, et al. Human genome epidemiology: a scientific foundation for using genetic information to improve health and prevent disease Oxford: Oxford University Press, Khoury JLWBM, 2004
4. Biological markers in environmental health research. NRC, N.R.C, Environ Health Perspect 1987 74 3 9 3691432
5. Molecular epidemiology and carcinogen-DNA adduct detection: new approaches to studies of human cancer causation. Perera FP, Weinstein IB, J Chronic Dis 1982 35 7 581 600 10.1016/0021-9681(82)90078-9 6282919 (Pubitemid 12085585)
6. Incorporating biomarkers into cancer epidemiology: a matrix of biomarker and study design categories. Rothman N, Stewart WF, Schulte PA, Cancer Epidemiol Biomarkers Prev 1995 4 4 301 311 7655323
7. HbA1c: how do we measure it and what does it mean? Little RR, Sacks DB, Curr Opin Endocrinol Diabetes Obes 2009 16 2 113 118 10.1097/MED. 0b013e328327728d 19300091
8. Biomarker risk assessment and bladder cancer detection in a cohort exposed to benzidine. Hemstreet GP 3rd, et al. J Natl Cancer Inst 2001 93 6 427 436 10.1093/jnci/93.6.427 11259468
9. How to avoid bias when comparing bone marrow transplantation with chemotherapy. Gray R, Wheatley K, Bone Marrow Transplant 1991 7 Suppl 3 9 12 1878737
10. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Davey Smith G, Ebrahim S, Int J Epidemiol 2003 32 1 1 22 10.1093/ije/dyg070 12689998 (Pubitemid 36503465)
11. Nanowire nanosensors for highly sensitive and selective detection of biological and chemical species. Cui Y, et al. Science 2001 293 5533 1289 1292 10.1126/science.1062711 11509722 (Pubitemid 32777412)
12. Russo VEA MR, Riggs AD, Epigenetic mechanisms of gene regulation Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press 1996
13. Allis CD, Jenuwein T, Reinberg D, Epigenetics Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press 2007
14. Epigenetics and microRNAs. Chuang JC, Jones PA, Pediatr Res 2007 61 5 Pt 2 24R 29R 17413852 (Pubitemid 46653064)
15. Epigenetics and environmental chemicals. Baccarelli A, Bollati V, Curr Opin Pediatr 2009 21 2 243 251 10.1097/MOP.0b013e32832925cc 19663042
16. The role of parental and grandparental epigenetic alterations in familial cancer risk. Fleming JL, Huang TH, Toland AE, Cancer Res 2008 68 22 9116 9121 10.1158/0008-5472.CAN-08-2184 19010880
17. Environmental epigenomics and disease susceptibility. Jirtle RL, Skinner MK, Nat Rev Genet 2007 8 4 253 262 10.1038/nrg2045 17363974 (Pubitemid 46439287)
18. Developmental origins of disease paradigm: a mechanistic and evolutionary perspective. Gluckman PD, Hanson MA, Pediatr Res 2004 56 3 311 317 10.1203/01.PDR.0000135998.08025.FB 15240866 (Pubitemid 39128811)
19. Epigenetic epidemiology of the developmental origins hypothesis. Waterland RA, Michels KB, Annu Rev Nutr 2007 27 363 388 10.1146/annurev.nutr.27. 061406.093705 17465856 (Pubitemid 351373362)
20. Case-control studies. In: Rothman KJ, Greenland S (eds). Modern Epidemiology. Ed. 2. Philadelphia. Rothman KJ, Greenland S, PA: Lippincott-Raven 1998 1998 93 114
21. Last J, Spasoff R, Harris S, A dictionary of epidemiology New York, NY: Oxford University Press 2001
22. Selection bias in the assessment of gene-environment interaction in case-control studies. Morimoto LM, White E, Newcomb PA, Am J Epidemiol 2003 158 3 259 263 10.1093/aje/kwg147 12882948 (Pubitemid 36944419)
23. Reliability of a flushing questionnaire and the ethanol patch test in screening for inactive aldehyde dehydrogenase-2 and alcohol-related cancer risk. Yokoyama A, et al. Cancer Epidemiol Biomarkers Prev 1997 6 12 1105 1107 9419411 (Pubitemid 28007425)
24. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. Stamey TA, et al. N Engl J Med 1987 317 15 909 916 10.1056/NEJM198710083171501 2442609 (Pubitemid 17147932)
25. Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower. Thompson IM, et al. JAMA 2005 294 1 66 70 10.1001/jama.294.1.66 15998892 (Pubitemid 41002840)
26. Obesity and prostate cancer: making sense out of apparently conflicting data. Freedland SJ, Platz EA, Epidemiol Rev 2007 29 88 97 10.1093/epirev/mxm006 17478439 (Pubitemid 47229642)
27. The effect of body mass index on PSA levels and the development, screening and treatment of prostate cancer. Skolarus TA, Wolin KY, Grubb RL 3rd, Nat Clin Pract Urol 2007 4 11 605 614 10.1038/ncpuro0944 17982437 (Pubitemid 350130557)
28. Variation in KLK genes, prostate-specific antigen and risk of prostate cancer. Ahn J, et al. Nat Genet 2008 40 9 1032 1034 author reply 1035-6 10.1038/ng0908-1032 19165914
29. Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer. Wiklund F, et al. Prostate 2009 69 4 419 427 10.1002/pros.20908 19116992
30. Detecting association in a case-control study while correcting for population stratification. Reich DE, Goldstein DB, Genet Epidemiol 2001 20 1 4 16 10.1002/1098-2272(200101)20:1<4::AID-GEPI2>3.0.CO;2-T 11119293
31. CYP3A4-V and prostate cancer in African Americans: causal or confounding association because of population stratification? Kittles RA, et al. Hum Genet 2002 110 6 553 560 10.1007/s00439-002-0731-5 12107441 (Pubitemid 36075004)
32. Point: population stratification: a problem for case-control studies of candidate-gene associations? Thomas DC, Witte JS, Cancer Epidemiol Biomarkers Prev 2002 11 6 505 512 12050090 (Pubitemid 34615157)
33. The future of genetic studies of complex human diseases: an epidemiologic perspective. Khoury MJ, Yang Q, Epidemiology 1998 9 3 350 354 10.1097/00001648-199805000-00023 9583430
34. Ethnic-affiliation estimation by use of population-specific DNA markers. Shriver MD, et al. Am J Hum Genet 1997 60 4 957 964 9106543 (Pubitemid 27146505)
35. Implementing a unified approach to family-based tests of association. Laird NM, Horvath S, Xu X, Genet Epidemiol 2000 19 Suppl 1 36 S42 11055368
36. Choosing a retrospective design to assess joint genetic and environmental contributions to risk. Weinberg CR, Umbach DM, Am J Epidemiol 2000 152 3 197 203 10.1093/aje/152.3.197 10933265 (Pubitemid 30640242)
37. Sample size requirements for matched case-control studies of gene-environment interaction. Gauderman WJ, Stat Med 2002 21 1 35 50 10.1002/sim.973 11782049 (Pubitemid 34065703)
38. Statistical analysis of molecular epidemiology studies employing case-series. Begg CB, Zhang ZF, Cancer Epidemiol Biomarkers Prev 1994 3 2 173 175 8049640
39. Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies. Piegorsch WW, Weinberg CR, Taylor JA, Stat Med 1994 13 2 153 162 10.1002/sim.4780130206 8122051 (Pubitemid 24017109)
40. Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls! Khoury MJ, Flanders WD, Am J Epidemiol 1996 144 3 207 213 10.1093/oxfordjournals.aje. a008915 8686689 (Pubitemid 26313497)
41. Case-parents design for gene-environment interaction. Schaid DJ, Genet Epidemiol 1999 16 3 261 273 10.1002/(SICI)1098-2272(1999)16:3<261::AID- GEPI3>3.0.CO;2-M 10096689 (Pubitemid 29115945)
42. Limitations of the case-only design for identifying gene-environment interactions. Albert PS, et al. Am J Epidemiol 2001 154 8 687 693 10.1093/aje/154.8.687 11590080 (Pubitemid 32971488)
43. Using risk-based sampling to enrich cohorts for endpoints, genes, and exposures. Weinberg CR, et al. Am J Epidemiol 2007 166 4 447 455 10.1093/aje/kwm097 17556763 (Pubitemid 47216791)
44. Sister study hopes to answer breast cancer questions. Medlin J, Environ Health Perspect 2001 109 8 368 A369 10.1289/ehp.109-a368 11564634
45. Cohort studies and the genetics of complex disease. Manolio TA, Nat Genet 2009 41 1 5 6 10.1038/ng0109-5 19112455
46. Genes, environment and the value of prospective cohort studies. Manolio TA, Bailey-Wilson JE, Collins FS, Nat Rev Genet 2006 7 10 812 820 10.1038/nrg1919 16983377 (Pubitemid 44413225)
47. Merging and emerging cohorts: necessary but not sufficient. Collins FS, Manolio TA, Nature 2007 445 7125 259 10.1038/445259a 17230172 (Pubitemid 46122800)
48. Merging and emerging cohorts: not worth the wait. Willett WC, et al. Nature 2007 445 7125 257 258 10.1038/445257a 17230171 (Pubitemid 46122799)
49. CHA, Children's Health Act 2000, Public Law 106-310 (codified at 42 USC 201) 2000 22857732
50. Principles of study design in environmental epidemiology. Morgenstern H, Thomas D, Environ Health Perspect 1993 101 Suppl 4 23 38 10.1289/ehp.93101s423 8206038 (Pubitemid 24075439)
51. Carroll RJ, Crainiceanu C, Ruppert D, Stefanski LA, Measurement Error in Nonlinear Models: A Modern Perspective Chapman and Hall, 2006
52. Does nondifferential misclassification of exposure always bias a true effect toward the null value? Dosemeci M, Wacholder S, Lubin JH, Am J Epidemiol 1990 132 4 746 748 2403115 (Pubitemid 20344542)
53. When will nondifferential misclassification of an exposure preserve the direction of a trend? Weinberg CR, Umbach DM, Greenland S, Am J Epidemiol 1994 140 6 565 571 8067350 (Pubitemid 24285939)
54. Correlated nondifferential misclassifications of disease and exposure: application to a cross-sectional study of the relation between handedness and immune disorders. Chavance M, Dellatolas G, Lellouch J, Int J Epidemiol 1992 21 3 537 546 10.1093/ije/21.3.537 1634317
55. Bias from nondifferential but dependent misclassification of exposure and outcome. Kristensen P, Epidemiology 1992 3 3 210 215 10.1097/00001648- 199205000-00005 1591319
56. Re: «Does nondifferential misclassification of exposure always bias a true effect toward the null value?» (Letter). Es G, Am J Epidemiol 1991 134 4 440 441
57. Differential misclassification and the assessment of gene-environment interactions in case-control studies. Garcia-Closas M, Thompson WD, Robins JM, Am J Epidemiol 1998 147 5 426 433 10.1093/oxfordjournals.aje.a009467 9525528 (Pubitemid 28146101)
58. Biomonitoring of polycyclic aromatic hydrocarbons in human urine. Jacob J, Seidel A, J Chromatogr B Analyt Technol Biomed Life Sci 2002 778 1-2 31 47 12376115
59. Measurement methods for human exposure analysis. Lioy PJ, Environ Health Perspect 1995 103 Suppl 3 35 43 10.1289/ehp.95103s335 8635438
60. Personalized exposure assessment: promising approaches for human environmental health research. Weis BK, et al. Environ Health Perspect 2005 113 7 840 848 10.1289/ehp.7651 16002370 (Pubitemid 40984182)
61. Environmental causes of central nervous system maldevelopment. Rodier PM, Pediatrics 2004 113 4 Suppl 1076 1083 15060202 (Pubitemid 38437361)
62. Intra-uterine methylmercury poisoning in Iraq. Amin-Zaki L, et al. Pediatrics 1974 54 5 587 595 4480317
63. Fetal methylmercury poisoning: clinical and toxicological data on 29 cases. Marsh DO, et al. Ann Neurol 1980 7 4 348 353 10.1002/ana.410070412 7377761 (Pubitemid 10112830)
64. Polychlorinated biphenyls and the developing nervous system: cross-species comparisons. Tilson HA, Jacobson JL, Rogan WJ, Neurotoxicol Teratol 1990 12 3 239 248 10.1016/0892-0362(90)90095-T 2115098 (Pubitemid 20344188)
65. The effects of maternal smoking during pregnancy on offspring outcomes. Agrawal A, et al. Prev Med 2010 50 1-2 13 18 20026103
66. Individual susceptibility to induced chromosome damage and its implications for detecting genotoxic exposures in human populations. Wiencke JK, et al. Cancer Res 1991 51 19 5266 5269 1913649
67. Smoking during pregnancy and diabetes mellitus in a British longitudinal birth cohort. Montgomery SM, Ekbom A, BMJ 2002 324 7328 26 27 10.1136/bmj.324.7328.26 11777801 (Pubitemid 34048849)
68. Human biomonitoring: state of the art. Angerer J, Ewers U, Wilhelm M, Int J Hyg Environ Health 2007 210 3-4 201 228 17376741 (Pubitemid 46618114)
69. The location of personal sampler filter filter heads. Chatterjee BB, et al. Am Ind Hyg Assoc J 1969 30 6 643 645 5369280
70. Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease. Hernan MA, et al. Epidemiology 2008 19 6 766 779 10.1097/EDE.0b013e3181875e61 18854702
71. Multivariate adaptive splines for analysis of longitudinal data. Zhang HP, J Comput Graph Stat 1997 6 74 91
72. Analysis of infant growth curves using multivariate adaptive splines. Zhang HP, Biometrics 1999 55 452 459 10.1111/j.0006-341X.1999.00452.x 11318199
73. A genome-wide association analysis of Framingham Heart Study longitudinal data using multivariate adaptive splines. Zhu W, et al. BMC Proc 2009 3 Suppl 7 119 10.1186/1753-6561-3-s7-s119 20017984
74. Nonparametric smoothing estimates of time-varying coefficient models with longitudinal data. Hoover DR, et al. Biometrika 1998 85 809 822 10.1093/biomet/85.4.809
75. KERNEL SMOOTHING ON VARYING COEFFICIENT MODELS WITH LONGITUDINAL DEPENDENT VARIABLE. Wu CO, Chiang C-T, Statistica Sinica 2010 10 2000 433 456
76. Tests for gene-environment interaction from case-control data: a novel study of type I error, power and designs. Mukherjee B, et al. Genet Epidemiol 2008 32 7 615 626 10.1002/gepi.20337 18473390
77. A statistical problem arising from retrospective studies. In Neyman, J. (ed.). Cornfield J, Proceedings of the Third Berkeley Symposium on Mathematical Statistics and Probability 1956 4 135 148
78. Logistic disease incidence models and case-control studies. Prentice RL, Pyke R, Biometrika 1979 66 403 411 10.1093/biomet/66.3.403 (Pubitemid 10218387)
79. Does accounting for gene-environment (GxE) interaction increase the power to detect the effect of a gene in a multifactorial disease? Selinger-Leneman H, et al. Genet Epidemiol 2003 24 3 200 207 10.1002/gepi.10221 12652524 (Pubitemid 36444185)
80. Powerful multilocus tests of genetic association in the presence of gene-gene and gene-environment interactions. Chatterjee N, et al. Am J Hum Genet 2006 79 6 1002 1016 10.1086/509704 17186459 (Pubitemid 44868070)
81. Exploiting gene-environment interaction to detect genetic associations. Kraft P, et al. Hum Hered 2007 63 2 111 119 10.1159/000099183 17283440
82. Maity, A.a.L., X, Powerful tests for detecting a gene effect in the presence of possible gene-gene interactions using garrotte kernel machines. Submitted 2010
83. Applications of the case-control method in genetic epidemiology. Khoury MJ, Beaty TH, Epidemiol Rev 1994 16 1 134 150 7925722 (Pubitemid 24217791)
84. Designing and analysing case-control studies to exploit independence of genotype and exposure. Umbach DM, Weinberg CR, Stat Med 1997 16 15 1731 1743 10.1002/(SICI)1097-0258(19970815)16:15<1731::AID-SIM595>3.0.CO;2-S 9265696 (Pubitemid 27355028)
85. Exploiting gene-environment independence in family-based case-control studies: increased power for detecting associations, interactions and joint effects. Chatterjee N, Kalaylioglu Z, Carroll RJ, Genet Epidemiol 2005 28 2 138 156 10.1002/gepi.20049 15593088
86. Semiparametric maximum likelihood estimation exploiting gene-environment independence in case-control studies. Chatterjee, N.a.C., R. J, Biometrika 2005 92 399 418 10.1093/biomet/92.2.399 (Pubitemid 40937643)
87. Population stratification bias in the case-only study for gene-environment interactions. Wang LY, Lee WC, Am J Epidemiol 2008 168 2 197 201 10.1093/aje/kwn130 18497429 (Pubitemid 351951599)
88. Use of siblings as controls in case-control association studies. Curtis D, Ann Hum Genet 1997 61 319 333 10.1017/S000348009700626X 9365785 (Pubitemid 27455302)
89. Family-based association studies. Gauderman WJ, Witte JS, Thomas DC, J Natl Cancer Inst Monogr 1999 26 31 37 10854483
90. Asymptotic bias and efficiency in case-control studies of candidate genes and gene-environment interactions: basic family designs. Witte JS, Gauderman WJ, Thomas DC, Am J Epidemiol 1999 149 8 693 705 10.1093/oxfordjournals.aje. a009877 10206618 (Pubitemid 29180777)
91. The use of case-parent triads to study joint effects of genotype and exposure. Umbach DM, Weinberg CR, Am J Hum Genet 2000 66 1 251 261 10.1086/302707 10631155 (Pubitemid 30481487)
92. Analysis of case-parental control studies: method for the study of associations between disease and genetic markers. Flanders WD, Khoury MJ, Am J Epidemiol 1996 144 7 696 703 10.1093/oxfordjournals.aje.a008982 8823066 (Pubitemid 26322522)
93. Study designs for genome-wide association studies. Kraft P, Cox DG, Adv Genet 2008 60 465 504 18358330
94. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. McCarthy MI, et al. Nat Rev Genet 2008 9 5 356 369 10.1038/nrg2344 18398418 (Pubitemid 351556063)
95. The future of genetic studies of complex human diseases. Risch N, Merikangas K, Science 1996 273 5281 1516 1517 10.1126/science.273.5281.1516 8801636 (Pubitemid 26301653)
96. Principal components analysis corrects for stratification in genome-wide association studies. Price AL, et al. Nat Genet 2006 38 8 904 909 10.1038/ng1847 16862161 (Pubitemid 44141658)
97. On multiple-testing correction in genome-wide association studies. Moskvina V, Schmidt KM, Genet Epidemiol 2008 32 6 567 573 10.1002/gepi.20331 18425821
98. Efficient multilocus association testing for whole genome association studies using localized haplotype clustering. Browning BL, Browning SR, Genet Epidemiol 2007 31 5 365 375 10.1002/gepi.20216 17326099 (Pubitemid 47050999)
99. Gene-environment interaction in genome-wide association studies. Murcray CE, Lewinger JP, Gauderman WJ, Am J Epidemiol 2009 169 2 219 226 19022827
100. Invited commentary: efficient testing of gene-environment interaction. Chatterjee N, Wacholder S, Am J Epidemiol 2009 169 2 231 233 discussion 234-5 19022825
101. Exploiting gene-environment independence for analysis of case-control studies: an empirical Bayes-type shrinkage estimator to trade-off between bias and efficiency. Mukherjee B, Chatterjee N, Biometrics 2008 64 3 685 694 10.1111/j.1541-0420.2007.00953.x 18162111
102. Epidemiological methods for studying genes and environmental factors in complex diseases. Clayton D, McKeigue PM, Lancet 2001 358 9290 1356 1360 10.1016/S0140-6736(01)06418-2 11684236 (Pubitemid 33016504)
103. Kalfleisch JD PR, The Statistical Analysis of Failure Time Data Wiley, New York, NY 2002
104. Diggle P, Heagerty P, Liang KY, Zeger S, Analysis of Longitudinal Data Oxford University Press, New York 2002
105. Multiplicative models and cohort analysis. Breslow NE, Lubin JH, Marek P, Langholtz B, J. Am. Statist. Assoc. 1983 78 1 12 10.1080/01621459.1983.10477915
106. Biased selection of controls for case-control analyses of cohort studies. Lubin JH, Gail MH, Biometrics 1984 40 1 63 75 10.2307/2530744 6375751
107. The Efficiency of Synthetic Retrospective Studies. Whittemore AS, Biom. J. 1981 23 73 78 10.1002/bimj.4710230110
108. Analyzing occupational cohort data: application to U.S. uranium miners. Whittemore AS, McMillan A, Environmental Epidemiology: Risk Assessment SIAM, Philadelphia, Prentice RL, Whittemore AS, 1982 65 81
109. A hybrid epidemiologic study design useful in estimating relative risk. Kupper LL, McMichael AJ, Spirtas R, J Am Stat Assoc 1975 70 524 528
110. Design options in epidemiologic research. An update. Miettinen O, Scand J Work Environ Health 1982 8 Suppl 1 7 14 6980462 (Pubitemid 12083633)
111. Estimating interaction between genetic and environmental risk factors: efficiency of sampling designs within a cohort. Bureau A, et al. Epidemiology 2008 19 1 83 93 10.1097/EDE.0b013e31815c4d0e 18091418 (Pubitemid 350295143)
112. Practical considerations in choosing between the case-cohort and nested case-control designs. Wacholder S, Epidemiology 1991 2 2 155 158 10.1097/00001648-199103000-00013 1932316
113. Nested case-control and case-cohort methods of sampling from a cohort: a critical comparison. Langholz B, Thomas DC, Am J Epidemiol 1990 131 1 169 176 2403467 (Pubitemid 20014710)
114. A two stage design for the study of the relationship between a rare exposure and a rare disease. White JE, Am J Epidemiol 1982 115 1 119 128 7055123 (Pubitemid 12205727)
115. Logistic regression analysis and efficient design for two-stage studies. Cain KC, Breslow NE, Am J Epidemiol 1988 128 6 1198 1206 3195561 (Pubitemid 19015493)
116. Improved Horvitz-Thompson Estimation of Model Parameters from Two-phase Stratified Samples: Applications in Epidemiology. Breslow NE, et al. Stat Biosci 2009 1 1 32 10.1007/s12561-009-9001-6 20174455
117. The design and analysis of case-control studies with biased sampling. Weinberg CR, Wacholder S, Biometrics 1990 46 4 963 975 10.2307/2532441 2085641
118. Sample size requirements in case-only designs to detect gene-environment interaction. Yang Q, Khoury MJ, Flanders WD, Am J Epidemiol 1997 146 9 713 720 10.1093/oxfordjournals.aje.a009346 9366618
119. Sample size/power calculation for case-cohort studies. Cai J, Zeng D, Biometrics 2004 60 4 1015 1024 10.1111/j.0006-341X.2004.00257.x 15606422 (Pubitemid 40019043)
120. On power and sample size for studying features of the relative odds of disease. Lubin JH, Gail MH, Am J Epidemiol 1990 131 3 552 566 2301364 (Pubitemid 20051751)
121. Minimum sample size estimation to detect gene-environment interaction in case-control designs. Hwang SJ, et al. Am J Epidemiol 1994 140 11 1029 1037 7985651
122. Power and sample size calculations for case-control studies of gene-environment interactions with a polytomous exposure variable. Foppa I, Spiegelman D, Am J Epidemiol 1997 146 7 596 604 10.1093/oxfordjournals.aje. a009320 9326439 (Pubitemid 28027261)